Switzerland · Delayed Price · Currency is CHF Medacta Group Statistics
Total Valuation
Medacta Group has a market cap or net worth of CHF 3.09 billion. The enterprise value is 3.29 billion.
| Market Cap | 3.09B |
| Enterprise Value | 3.29B |
Important Dates
The next estimated earnings date is Tuesday, December 9, 2025.
| Earnings Date | Dec 9, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Medacta Group has 19.94 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 19.94M |
| Shares Outstanding | 19.94M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 13.28% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 34.82 and the forward PE ratio is 33.98.
| PE Ratio | 34.82 |
| Forward PE | 33.98 |
| PS Ratio | 5.12 |
| PB Ratio | 7.79 |
| P/TBV Ratio | 8.94 |
| P/FCF Ratio | 77.80 |
| P/OCF Ratio | 23.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.82, with an EV/FCF ratio of 83.01.
| EV / Earnings | 37.16 |
| EV / Sales | 5.46 |
| EV / EBITDA | 20.82 |
| EV / EBIT | 32.66 |
| EV / FCF | 83.01 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.39 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 1.50 |
| Debt / FCF | 6.00 |
| Interest Coverage | 7.42 |
Financial Efficiency
Return on equity (ROE) is 24.70% and return on invested capital (ROIC) is 10.76%.
| Return on Equity (ROE) | 24.70% |
| Return on Assets (ROA) | 8.48% |
| Return on Invested Capital (ROIC) | 10.76% |
| Return on Capital Employed (ROCE) | 15.98% |
| Revenue Per Employee | 295,646 |
| Profits Per Employee | 43,442 |
| Employee Count | 1,907 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 0.85 |
Taxes
In the past 12 months, Medacta Group has paid 15.67 million in taxes.
| Income Tax | 15.67M |
| Effective Tax Rate | 15.02% |
Stock Price Statistics
The stock price has increased by +40.73% in the last 52 weeks. The beta is 1.14, so Medacta Group's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +40.73% |
| 50-Day Moving Average | 148.86 |
| 200-Day Moving Average | 139.81 |
| Relative Strength Index (RSI) | 59.45 |
| Average Volume (20 Days) | 11,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medacta Group had revenue of CHF 603.41 million and earned 88.67 million in profits. Earnings per share was 4.45.
| Revenue | 603.41M |
| Gross Profit | 407.98M |
| Operating Income | 100.86M |
| Pretax Income | 104.33M |
| Net Income | 88.67M |
| EBITDA | 150.99M |
| EBIT | 100.86M |
| Earnings Per Share (EPS) | 4.45 |
Balance Sheet
The company has 31.05 million in cash and 238.00 million in debt, giving a net cash position of -206.96 million or -10.38 per share.
| Cash & Cash Equivalents | 31.05M |
| Total Debt | 238.00M |
| Net Cash | -206.96M |
| Net Cash Per Share | -10.38 |
| Equity (Book Value) | 396.58M |
| Book Value Per Share | 19.88 |
| Working Capital | 240.59M |
Cash Flow
In the last 12 months, operating cash flow was 129.12 million and capital expenditures -89.44 million, giving a free cash flow of 39.68 million.
| Operating Cash Flow | 129.12M |
| Capital Expenditures | -89.44M |
| Free Cash Flow | 39.68M |
| FCF Per Share | 1.99 |
Margins
Gross margin is 67.61%, with operating and profit margins of 16.72% and 14.69%.
| Gross Margin | 67.61% |
| Operating Margin | 16.72% |
| Pretax Margin | 17.29% |
| Profit Margin | 14.69% |
| EBITDA Margin | 25.02% |
| EBIT Margin | 16.72% |
| FCF Margin | 6.58% |
Dividends & Yields
This stock pays an annual dividend of 0.69, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | 0.69 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | 25.45% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 15.44% |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.48% |
| Earnings Yield | 2.87% |
| FCF Yield | 1.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medacta Group has an Altman Z-Score of 5.77 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.77 |
| Piotroski F-Score | 6 |